Insider Activity and Recent Financing Boost Confidence in Apogee Therapeutics
Michael Thomas Henderson, CEO of Apogee Therapeutics (NASDAQ:APGE), recently sold a significant block of company stock. This transaction happens while the company is experiencing strong external validation through multiple price target increases from major analyst firms and having successfully completed a substantial stock offering.